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Background: Although body fat percent (BF%) may be used for screening metabolic risk factors, its accuracy
compared to BMI and waist circumference is unknown in a Mexican population. We compared the classification
accuracy of BF%, BMI and WC for the detection of metabolic risk factors in a sample of Mexican adults; optimized
cutoffs as well as sensitivity and specificity at commonly used BF% and BMI international cutoffs were estimated.
We also estimated conditional BF% means at BMI international cutoffs.
Methods: We performed a cross-sectional analysis of data on body composition, anthropometry and metabolic risk
factors(high glucose, high triglycerides, low HDL cholesterol and hypertension) from 5,100 Mexican men and women.
The association between BMI, WC and BF%was evaluated with linear regression models. The BF%, BMI and WC optimal
cutoffs for the detection of metabolic risk factors were selected at the point where sensitivity was closest to specificity.
Areas under the ROC Curve (AUC) were compared among classifiers using a non-parametric method.
Results: After adjustment for WC, a 1% increase in BMI was associated with a BF% rise of 0.05 percentage points (p.p.)
in men (P < 0.05) and 0.25 p.p. in women (P < 0.001). At BMI = 25.0 predicted BF% was 27.6 ± 0.16 (mean ± SE) in men
and 41.2 ± 0.07 in women. Estimated BF% cutoffs for detection of metabolic risk factors were close to 30.0 in men and
close to 44.0 in women. In men WC had higher AUC than BF% for the classification of all conditions whereas BMI had
higher AUC than BF% for the classification of high triglycerides and hypertension. In womenBMI and WC had higher
AUC than BF% for the classification of all metabolic risk factors.
Conclusions: BMI and WC were more accurate than BF% for classifying the studied metabolic disorders. International
BF% cutoffs had very low specificity and thus produced a high rate of false positives in both sexes.Background
Body fat (BF) is a tissue with endocrine and immune func-
tions [1]. When overweight or obesity are present, these
characteristics make BF a determinant of metabolic disor-
ders such as insulin resistance and Metabolic syndrome
[2]. Overweight and obesity are highly prevalent in the
Mexican population [3], and; nationwide representative
surveys have shown that 41.6% of Mexican adults have
metabolic syndrome [4]. Evaluating BF and its distribution
in the Mexican population is thus useful for screening for
metabolic risk factors.* Correspondence: amado.quezada@insp.mx
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unless otherwise stated.Indicators such as BMI and waist circumference (WC)
are frequently used to define overweight and obesity,
despite the fact that they do not directly measure adi-
posity. While epidemiological studies have shown these
indicators to be useful predictors of non-communicable
diseases and mortality risk [5,6], their ability to predict
BF has been questioned. Okorodudu et al. [7], in a meta-
analysis assessing BMI’s performance in estimating BF%,
found that BMI ≥ 30 has good specificity and predictive
value for detecting excess adiposity independently of sex,
but the authors did not explore the influence of ethnicity
on BMI’s performance. This is important since BF% in
Caucasians is different from other ethnic groups BF% at
the same BMI categories [8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pond to the international BMI cutoff points as defined by
the World Health Organization (WHO) or the relative
performance of BF% for classifying metabolic risk factors
in Mexicans. The variations between BF%, BMI and WC
in non-Caucasian populations, as well as the high preva-
lence of metabolic syndrome in Mexicans, highlight the
need to assess BF% and the most commonly adiposity in-
dicators cutoff points used for the purpose of the detec-
tion of metabolic risk factors in Mexican adults.
Methods
Study design and sample
We performed a cross-sectional analysis of baseline data
from participants in a cohort study focused on lifestyle
and chronic disease (The Health Worker Cohort Study
or HWCS) [9]. Briefly, 9467 health care employees from
three health and academic institutions in the states of
Mexico and Morelos were invited to participate (March
2004-April 2006). Each worker signed informed consent
forms, and the study protocol was approved by the
Mexican Institute for Social Security (Instituto Mexicano
del Seguro Social) ethics committee.
The analysis was restricted to subjects aged 20 to
65 years, with body composition and blood sample deter-
minations. Subjects with type-2 diabetes, cancer or other
chronic diseases that are known to alter body composition
were also excluded. The final analytical sample was com-
posed by 5100 subjects.
Body composition, anthropometric and biochemical
measurements
BF% was determined by DEXA (Lunar DPX-GE, Lunar
Radiation; software version 1.35, fast scan mode). Weight
was measured to the nearest 100 g (TANITA BC-533).
Height was measured while barefoot participants were
standing on a flat surface. Waist circumference was measured
at the highest point of the iliac crest to the nearest 0.1 cm
[10]. Venous blood samples were collected after 8-hours
of fasting. Plasma glucose was measured using the glucose
oxidize colorimetric method, serum triglyceride concen-
trations were assayed with a colorimetric method follow-
ing hydrolysis by lipase, and serum HDL cholesterol was
assessed by the clearance method. All biomedical assays
were performed with a Selectra XL instrument (Randox,
MA USA) in accordance with international proceedings
[11]. Trained nurses measured blood pressure with an
automatic digital blood pressure monitor while participants
were seated with their right arm resting at heart level.
Variable definitions
The BF% cutoffs chosen to perform sensitivity and specifi-
city comparisons were the values most frequently cited by
international scientific literature (BF% ≥ 20 and BF% ≥ 25for men; BF% ≥ 30 and BF% ≥ 35 for women) [7]. The
waist circumference cutoff points used were those recom-
mended by the Mexican Health Ministry (WC ≥ 90 for
men and WC ≥ 80 for women) and the NCEP/ATP III re-
vised guidelines (WC ≥ 102 for men and WC ≥ 88 for
women) [2]. For both sexes, overweight was defined as
BMI ≥ 25 and obesity as BMI ≥ 30 [12].
Metabolic risk factors were defined as high fasting glucose
(≥100 mg/dL) [13], high serum triglycerides (≥150 mg/dL)
[13], low serum HDL cholesterol (<40 mg/dL in men
or <50 mg/dL in women) [2] and high blood pressure
(systolic blood pressure >140 mm Hg or diastolic blood
pressure >90 mm Hg) [14].
Statistical analysis
The association between BMI, WC and BF% was evalu-
ated with three regression models estimated for each sex
separately using a linear-log specification, which enables
to estimate the approximate change in the dependent vari-
able associated with a 1% increase in a given independent
variable when its regression coefficient is divided by 100
[15]. This model specification was motivated by looking at
scatter plots of the dependent variable vs. each covariate
and the pattern described by non parametric (lowess) re-
gressions. In the first model the log of BMI was included
as a predictor of BF%, in the second model the log of WC
was used as a predictor and the third model incorporated
both log BMI and log WC. The percentage of explained
variation was compared among models. All analyses were
conducted using Stata version 12.1 [16].
The BF%, BMI and WC optimal cutoffs were selected at
the point where sensitivity was closest to specificity [17].
Bootstrap percentile 95% confidence intervals were calcu-
lated for the optimized cutoffs, sensitivity and specificity,
using 1000 replicates [18]. The areas under ROC curves
(AUC) were compared among classifiers using a nonpara-
metric method [19].Results
General characteristics of the sample
A total of 3646 women (71.5% of the sample) and 1454
men (28.5% of the sample) were evaluated, and their char-
acteristics are summarized in Table 1. On average, men
were heavier, taller, and had larger WC than women.
Women had a BF% mean 13.0 percentage points (p.p.)
higher than men (P < 0.001). Average BF% for men was
24.4, 30.8 and 35.8 for the normal, overweight or obese
BMI categories, respectively. For women, BF% was 38.0,
44.2 and 49.3 for the normal, overweight and obese BMI
categories. The high glucose and hypertension prevalence
were around 25% in men and around 15% in women. In
men, the prevalences of high triglycerides and low HDL
cholesterol were approximately 60% whereas roughly one
Table 1 Characteristics of study subjects
Men (n = 1,454) Women (n = 3,646)
Mean ± SD Median [Min, Max] Mean ± SD Median [Min, Max]
Age (years) 41.4 ± 10.9 41.0 [20, 65] 41.3 ± 10.9 41.0 [20, 65]
Weight (kg) 76.5 ± 12.7 75.4 [41.9, 161.5] 64.4 ± 11.4 62.8 [40.3, 144.2]
Height (m) 168.7 ± 6.8 169.0 [137, 193] 155.8 ± 6.1 156.0 [136, 180]
Adiposity indicators
BMI (kg/m2) 26.8 ± 3.9 26.6 [18.5, 54.4] 26.5 ± 4.5 25.8 [18.5, 52.2]
Waist (cm) 93.0 ± 10.2 92.0 [64, 159] 88.9 ± 11.7 88.0 [58, 152]
Hip (cm) 98.2 ± 7.6 97.0 [80, 146] 100.3 ± 9 99.0 [70, 158]
Waist/hip ratio 0.9 ± 0.1 0.9 [0.7, 1.1] 0.9 ± 0.1 0.9 [0.6, 1.2]
Waist/height ratio 0.6 ± 0.1 0.5 [0.4, 0.9] 0.6 ± 0.1 0.6 [0.4, 1]
BF (%) 29.6 ± 7 29.8 [6.0, 58.2] 42.6 ± 6.3 43.0 [16.7, 65.5]
BFM (kg) 22 ± 8.1 21.3 [2.8, 74.3] 26.5 ± 8.1 25.3 [6.9, 80.8]
Metabolic indicators
Glucose (mg/dL) 96.2 ± 24.8 92.0 [58, 361] 90.3 ± 20.2 88.0 [51, 346]
Triglycerides (mg/dL) 211.7 ± 165.8 175.0 [30, 2490] 143.2 ± 90.6 122.0 [30, 1702]
c-HDL (mg/dL) 37.6 ± 8.6 37.0 [12, 78] 40.0 ± 12.1 39.0 [5, 365]
DBP (mm/Hg) 75.6 ± 10.8 75.0 [42, 124] 71.0 ± 9.6 70.0 [41, 115.3]
SBP (mm/hg) 124.4 ± 13.7 123 [80.7, 235] 114.5 ± 12.6 112 [66, 178]
Prevalence of metabolic risk factors (%)
High glucose1 27.2 14.9
High triglycerides2 61.1 34.5
Low HDL cholesterol3 62.2 83.6
Hypertension4 21.5 16.0
DBP = Diastolic Blood Pressure; SBP = Systolic Blood Pressure.
1Glucose ≥ 100 mg/dL.
2Triglycerides ≥ 150 mg/dL.
3HDL <40 mg/dL for men and <50 mg/dL for women.
4SBP >140 mmHg or DBP > 90 mmHg.
All comparisons were statistically significant (P < 0.05) but age.
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sented low HDL cholesterol.
BMI and waist circumference associations with body fat
percent
In men a BMI increase of 1% was associated with a BF%
rise of 0.33 p.p. (Table 2) when using log(BMI) as a single
predictor (Model 1). This association weakened when bothTable 2 Models for predicting body fat, by sex
Men (n = 1,454)
Model 1 Model 2 Model 3
Log (BMI)§ 0.330** (0.011) 0.050* (0.0
Log (WC)§ 0.483** (0.014) 0.428** (0.0
Constant -78.7** (3.62) -189.1** (6.16) -180.5** (7
R2 (%) 43.8 55.6 55.9
§Estimates were divided by 100 in order to approximate associated change in the o
Standard errors in parenthesis.
*P < 0.05, **P < 0.001.
All regression coefficients differed by sex (P < 0.01).log(BMI) and log(WC) were included as predictors. In
Model 3, a 1% WC increase was associated with an in-
crease of approximately 0.43 p.p. in BF%; once adjusted
for WC a 1% increase in BMI related to an increase of
0.05 p.p. in BF%. In men, as a single predictor log(WC) ac-
counts for more variation than log (BMI) and only 0.3 p.p.
of explained variation is added when both predictors are
used; together they account for 55.9% of BF% variation.Women (n = 3,646)
Model 1 Model 2 Model 3
21) 0.295** (0.005) 0.245** (0.007)
28) 0.318** (0.006) 0.082** (0.008)
.43) -53.8** (1.60) -100.1** (2.84) -73.9** (2.70)
56.4 41.9 57.5
utcome variable for a 1% increase in a given predictor.
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http://www.biomedcentral.com/1471-2458/14/341In contrast, in women log(BMI) accounts for more
variation (R2) than log(WC) and its coefficient remains
relatively stable when adding log(WC) as a predictor. In
the model with both predictors, a 1% increase of BMI
was associated with about 0.25 p.p. rise in BF% whereas
a 1% increase in WC was associated with approximately
0.08 p.p. rise in BF%. The log(BMI) alone accounts for
an amount of variation similar to both predictors jointly
(56.4% vs 57.5%).
In Model 1 the BF% conditioned means at BMI = 25
were 27.6 ± 0.16 (mean ± SE) for men and 41.2 ± 0.07 for
women; at BMI = 30 they were 34.7 ± 0.20 for men and
47.6 ± 0.10 for women. In Model 2, men’s BF% condi-
tioned means were 28.3 ± 0.13 at WC= 90 and 34.3 ± 0.16
at WC= 102 whereas women’s BF% conditioned means
were 39.5 ± 0.11 at WC= 80 and 42.5 ± 0.08 at WC= 88.
ROC analysis
Optimized BF% cutoff values for the classification of meta-
bolic risks were close to 30.0 in men (Table 3) and close to
44.0 in women (Table 4). In men, estimated BMI cutoffs
ranged from 26.3 to 27.2 and WC cutoffs from 92.0 to 94.0.
In women, optimized BMI cutoffs ranged from 26.2 to 27.2
and WC cutoffs from 89 to 91, except for HDL < 50.
In men, WC showed more discriminatory power
(higher AUC) than BF% for the classification of all meta-
bolic risk factors (Table 3) whereas BMI outperformed
BF%for the classification of high triglycerides and high
blood pressure. Sensitivity and specificity were around
57 at BF% optimized cutoffs. In contrast, BF% reference
cutoff of 20 showed a very high sensitivity (>90) but low
specificity (<20), similarly, the second reference at BF% = 25
showed high sensibility and low specificity. In women,
BMI had better discriminatory power than both WC
and BF% for the classification of all metabolic risk factors
(Table 4), except for HDL < 50 classification for which
BMI showed a higher AUC than BF but a lower AUC than
WC. WC outperformed BF% for the classification of all
conditions. At BF% optimized cutoffs sensitivity and speci-
ficity were approximately 60 for high glucose and were
both between 56 and 58 for classifying the rest of risk
factors. Even more markedly than for men, most refer-
enced cutoffs for women had very high sensibility (>97
for BF% = 30.0 and >88 for BF% = 35.0) but very low
specificity (<6 for BF = 30.0 and <17 for BF% = 35.0).
In women, BMI cutoff at 25 had high sensibility (>78)
and low specificity (<47) for high glucose and hyperten-
sion. On the other hand, at the obesity cutoff sensibility
was low (<42) and specificity was high (>84) for all meta-
bolic risk factors. Waist cutoff at 80.0 cm had high sens-
ibility (>80) and low specificity (<35) whereas the NCEP/
ATP III cutoff had sensibility around 75 and specificity
around 55 for classifying high glucose and relatively bal-
anced sensibility and specificity for the rest of risk factors.See Additional files 1 and 2 for the graphical representa-
tion of ROC analyses.
Discussion
The objective of the present study was to evaluate the
accuracy of BF%, BMI and WC for detecting metabolic
risk factors in Mexican adults. We also predicted BF%
points in accordance with WHO definitions of over-
weight and obesity based on BMI.
In the population under study, the WHO international
BMI cutoff point for classifying overweight overestimated
cases with metabolic risk factors. In contrast, the obesity
BMI cutoff overestimated the proportion of healthy sub-
jects. For women, the WC cutoff points used in health ser-
vices and by the NCEP/ATP III incorrectly classified a
high portion of healthy people as women with metabolic
risk factors; on the other hand, for men the NCEP/ATP
cutoffs had higher specificity than sensibility.
The AUC values showed that in general BMI and WC
were more accurate than BF% for classifying subjects with
metabolic risk factors. This result highlight the usefulness
of BMI and WC for public health purposes given their
higher accuracy and low cost for measurement. In a recent
study [20] in which BF% was determined by bioelectrical
impedance, BMI also performed better than BF% as meta-
bolic syndrome components classifier. These unexpected
results may be due to the measurement error attributable
to the determination of BF%. It may be relevant to use
more reliable methods to measure body composition such
as four compartment models to assess the relationship be-
tween body composition and metabolic risk factors and to
compare its classification accuracy with respect to BMI.
In regard to DEXA accuracy, some researchers have per-
formed in vitro validation studies. Individual chemical ana-
lyses of piglet’s skin, Body Fat Mass (BFM), Fat Free Mass
(FFM) and bone showed that DEXA underestimate BFM
values. [21] A plausible explanation about this underesti-
mation is the fact that BFM is surrounded by subcutane-
ous, intramuscular and visceral tissue plus connective
tissue, nervous and blood supply system. These compo-
nents are not considered in DEXA attenuation coefficient
used to estimate BFM [21]. Moreover, DEXA validation
studies that have used 4 compartment models as gold
standard in healthy adults found that BFM obtained with
DEXA underestimate the values obtained with method 4
Compartment model. The DEXA bias was not necessarily
attributable to variations in fat-free mass hydration and in-
stead the bias may be related to differences in anterior-
posterior tissue thickness [22]. In concordance with these
findings, other authors have indicated that body size may
bias BF obtained with DEXA through “the effect of tissue
depth; with increasing tissue depth associated with greater
bias” [23]. On the other hand, some studies have demon-
strated that Hispanics have more hepatic fat than other
Table 3 Cutoff estimation and AUC comparison between classifiers in adult men
Body fat % BMI (kg/m2) Waist (cm)
Estimated Reference I Reference II Estimated Overweight Obesity Estimated Reference NCEP/ATP III
Glucose ≥ 100 mg/dL; n = 1,439
Cutoff 30.5 (30.1, 30.9) 20 25 27.0 (26.7, 27.2) 25 30 94.0 (93.0, 95.0) 90 102
Sensitivity 58.3 (55.8, 61.1) 95.1 (92.8, 97.1) 87.0 (83.6, 90.3) 60.9 (57.3, 63.4) 80.6 (76.5, 84.4) 27.4 (22.8, 31.7) 60.6 (57.0, 64.2) 76.0 (71.9, 80.3) 28.9 (24.6, 33.6)
Specificity 58.4 (55.7, 61.0) 10.2 (8.5, 12.2) 25.3 (22.7, 28.2) 60.9 (57.3, 63.5) 37.9 (34.8, 40.9) 85.1 (83.0, 87.3) 59.9 (57.0, 64.4) 43.1 (40.2, 46.1) 85.2 (82.9, 87.5)
AUC 0.611 (0.579, 0.644) 0.639 (0.607, 0.670) 0.647b (0.616, 0.678)
Triglycerides ≥ 150 mg/dL; n = 1,439
Cutoff 29.6 (29.2, 30.0) 20 25 26.3 (26.1, 26.6) 25 30 92.0 (92.0, 93.0) 90 102
Sensitivity 58.7 (55.5, 61.4) 96.6 (95.3, 97.7) 86.5 (84.2, 88.9) 62.3 (59.7, 65.3) 77.5 (74.7, 80.1) 21.8 (19.1, 24.6) 63.0 (57.1, 65.2) 71.3 (68.5, 74.2) 22.1 (19.5, 24.6)
Specificity 58.8 (55.5, 61.4) 17.1 (14.3, 20.4) 35.2 (30.9, 39.6) 62.3 (59.8, 65.4) 49.1 (45.0, 53.2) 87.3 (84.5, 90.0) 60.0 (57.7, 64.6) 52.5 (48.2, 56.6) 86.8 (83.9, 89.5)
AUC 0.635 (0.605, 0.665) 0.674a (0.645, 0.703) 0.656b (0.627, 0.686)
HDL < 40 mg/dL; n = 1,422
Cutoff 29.6 (29.2, 30.1) 20 25 26.5 (26.2, 26.7) 25 30 92.0 (92.0, 93.0) 90 102
Sensitivity 55.7 (52.9, 58.2) 93.3 (91.6, 95.0) 82.0 (79.4, 84.6) 56.0 (53.6, 58.8) 72.2 (69.0, 75.1) 21.4 (18.6, 24.1) 59.5 (53.2, 61.6) 68.0 (64.7, 71.1) 22.9 (20.2, 25.5)
Specificity 55.7 (52.9, 58.3) 12.5 (9.9, 15.3) 28.9 (25.1, 32.8) 56.1 (53.5, 58.8) 41.2 (36.9, 45.6) 86.6 (83.8, 89.4) 55.5 (53.6, 60.8) 48.2 (44.3, 52.5) 88.5 (85.8, 91.1)
AUC 0.583 (0.553, 0.614) 0.587 (0.556, 0.617) 0.607b,c (0.577, 0.637)
SBP > 140 or DBP > 90 mmHg; n = 1,439
Cutoff 30.4 (29.9, 30.8) 20 25 27.2 (27.0, 27.5) 25 30 94.0 (94.0, 95.0) 90 102
Sensitivity 55.7 (52.9, 58.6) 94.8 (92.2, 97.1) 84.1 (80.3, 87.7) 63.4 (60.2, 66.0) 85.4 (81.6, 89.3) 31.7 (25.6, 37.5) 63.8 (57.6, 65.4) 77.3 (72.5, 81.9) 31.1 (26.2, 35.9)
Specificity 55.7 (53.0, 58.6) 9.8 (8.1, 11.6) 24.1 (21.5, 26.5) 63.3 (60.3, 66.1) 38.3 (35.8, 41.2) 85.4 (83.3, 87.3) 59.6 (57.6, 64.8) 42.6 (39.7, 45.3) 84.7 (82.6, 86.6)
AUC 0.578 (0.540, 0.604) 0.680a (0.635, 0.695) 0.650b, c (0.602, 0.664)
Sensitivity and Specificity expressed as percentages. Bootstrap percentile 95% confidence intervals in parentheses for optimized cutoff, sensitivity and specificity. Asymptotic normal 95% confidence intervals in




















Table 4 Cutoff estimation and AUC comparison between classifiers in adult women
Body fat % BMI (kg/m2) Waist (cm)
Estimated Reference I Reference II Estimated Overweight Obesity Estimated Reference NCEP/ATP III
Glucose ≥ 100 mg/dL; n = 3,625
Cutoff 44.0 (43.8, 44.4) 30 35 27.2 (26.8, 27.4) 25 30 91.0 (90.0, 91.0) 80 88
Sensitivity 60.9 (58.8, 63.1) 99.6 (99.1, 100.0) 94.8 (92.9, 96.6) 66.4 (64.1, 68.6) 84.0 (81.0, 87.1) 41.2 (36.8, 45.5) 62.3 (60.9, 66.8) 93.1 (90.9, 95.2) 74.6 (71.1, 78.1)
Specificity 60.9 (58.8, 63.0) 3.8 (3.1, 4.5) 13.3 (12.1, 14.5) 66.4 (64.2, 68.7) 46.1 (44.3, 47.8) 85.2 (84.0, 86.5) 65.6 (60.6, 66.9) 23.8 (22.3, 25.2) 54.0 (52.2, 55.7)
AUC 0.645 (0.620, .669) 0.723a (0.700, 0.745) 0.703b, c (0.679,0.726)
Triglycerides ≥ 150 mg/dL; n = 3,627
Cutoff 43.3 (43.1, 43.5) 30 35 26.2 (26.0, 26.4) 25 30 89.0 (88.0, 89.0) 80 88
Sensitivity 56.0 (54.4, 58.0) 98.6 (97.9, 99.2) 93.2 (91.8, 94.5) 61.0 (59.4, 62.7) 73.8 (71.3, 76.1) 26.7 (24.1, 29.3) 58.4 (56.4, 61.3) 89.1 (87.5, 90.8) 62.2 (59.5, 64.9)
Specificity 56.0 (54.3, 58.0) 4.3 (3.5, 5.1) 14.9 (13.4, 16.3) 61.1 (59.3, 62.8) 49.7 (47.8, 51.9) 85.4 (84.1, 86.8) 60.2 (56.2, 62.0) 26.8 (25.2, 28.6) 55.9 (54.0, 57.9)
AUC 0.584 (0.565, 0.603) 0.652a (0.634, 0.671) 0.633b, c (0.615, 0.651)
HDL < 50 mg/dL; n = 3,614
Cutoff 42.3 (42.0, 42.7) 30 35 25.3 (25.1, 25.5) 25 30 86.0 (86.0, 87.0) 80 88
Sensitivity 56.2 (53.9, 58.4) 97.1 (96.4, 97.7) 88.8 (87.6, 89.9) 57.6 (55.4, 59.6) 60.9 (59.2, 62.5) 20.2 (18.8, 21.7) 60.9 (55.8, 62.0) 81.4 (80.0, 82.8) 53.1 (51.3, 54.8)
Specificity 56.2 (53.9, 58.4) 5.2 (3.4, 7.1) 16.7 (13.8, 19.7) 57.6 (55.4, 59.6) 54.4 (50.2, 58.8) 88.9 (86.2, 91.2) 57.4 (56.4, 61.8) 34.8 (31.0, 38.7) 64.3 (60.4, 68.0)
AUC 0.577 (0.552, 0.602) 0.595a (0.570, 0.619) 0.629b, c (0.604, 0.653)
SBP > 140 or DBP > 90 mmHg; n = 3,613
Cutoff 43.8 (43.5, 44.1) 30 35 26.6 (26.4, 26.9) 25 30 90.0 (89.0, 90.0) 80 88
Sensitivity 58.1 (55.5, 60.1) 98.1 (96.9, 99.1) 91.7 (89.6, 93.8) 60.8 (59.1, 63.1) 78.5 (75.4, 81.8) 34.5 (30.6, 38.3) 58.2 (56.5, 62.4) 89.1 (86.3, 91.7) 66.2 (66.2, 70.4)
Specificity 58.1 (55.5, 60.1) 3.5 (2.9, 4.2) 12.8 (11.7, 14.0) 60.8 (59.1, 63.1) 45.5 (43.8, 47.1) 84.4 (83.1, 85.6) 60.4 (56.2, 62.0) 23.4 (21.9, 24.7) 52.8 (51.0, 54.6)
AUC 0.605 (0.578, 0.625) 0.662a (0.639, 0.684) 0.643b, c (0.613, 0.659)
Sensitivity and Specificity expressed as percentages. Bootstrap percentile 95% confidence intervals in parentheses for optimized cutoff, sensitivity and specificity. Asymptotic normal 95% confidence intervals in
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http://www.biomedcentral.com/1471-2458/14/341ethnic groups. Such differences maintain their significance
after BMI adjustment. Moreover, Hispanics have a higher
deep subcutaneous vs deep visceral fat tissue ratio than
other groups [24]. The lowest AUC values for DEXA ob-
tained in the present study may be explained by the in-
duced error of measurement in relation to this method
disability to detect deep BFM compartments. Although we
recognize DEXA limitations to detect BFM, it is important
to report body composition relationship with cardiovascu-
lar risk factors in our population. In the authors knowledge
this is one of the few studies that may exemplify the ab-
sence of appropriate BF% cutoffs to identify people with
cardiovascular risk in Latino American groups. There is
currently no consensus about the use of BF% to define
overweight and obesity as there is for using WHO BMI
categories and WC in the Mexican population.
In the present study, means of BF% at the overweight
BMI category were 30.8 for men and 44.2 for women. At
the obesity BMI category BF% means were 35.8 for men
and 49.3 for women. In a comparison of different ethnic
groups, Gallagher et al. [8] found that African Americans
had lower BF% predicted values than White Americans at
the same BMI categories and young adult Asians had
higher BF% predicted values in comparison with White
Americans. Our BF% estimates at BMI categories were
higher than those reported for these three ethnicities in
Gallagher’s study. These results underscore the relevance
of exploring the relationship between BF%, BMI and ill-
ness risk in different ethnic populations. Our findings sug-
gest that ethnic differences may cause significant variation
in body composition which appears to render the use of
international BF% cutoffs inappropriate in the Mexican
population.
Okorodudu et al., performed a meta-analysis evaluating
BMI’s performance in detecting BF% [7]. They found that
international BMI categories used for determining obesity
have a high specificity and low sensitivity for identifying
adiposity. This means that the BMI obesity cutoff does not
adequately identify people with BF% excess.
Our estimated WC cutoff values for men were lower
than 102 cm, value purposed by the NCEP/ATPIII initia-
tive. For women, except for HDL < 50, WC cutoff values
were greater than that recommended by NCEP/ATPIII
and the one currently used for Mexican population. The
sensitivity and specificity that we found for WC indicated
that WC can be used to classify metabolic risk factors in
Mexican men. In contrast, our results suggest that the
election of WC cutoff points for women should be deter-
mined by the metabolic risk factor that will be evaluated.
Lahmann et al. [25] evaluated the association between
adiposity measures and causes of mortality in Swedish
middle-aged and older men and women. For women and
men who were similar in age to the population evaluated
by the present study, BF% of 35.0 and 25.0 respectively,and the highest quintile of WC were associated with the
highest mortality risk. Although these cutoff values coin-
cide with internationally most used BF% cutoffs, our re-
sults highlight the necessity of validating such cutoffs in
different ethnic groups. Similarly, Joseph et al. [26] evalu-
ated BF% cutoff values in Asian Indians to identify their risk
of presenting cardiovascular factors. They found that 25.5
and 38.0 BF% were adequate to predict cardiovascular risk,
for men and women respectively. Values reported for these
authors are lower than those that we obtained; these results
strengthen the need for population-specific assessment.
BF% cutoff values obtained with ROC analyses for men
and women in the present study were higher than the inter-
national most used cutoff points in Caucasian populations.
At international WHO BMI cutoffs for overweight and
obesity, we found higher BF% predicted values than those
reported for Mexican-Americans [27], especially in women.
Fernandez JR et al. [28] evaluated BF% with DEXA and
its association with BMI. They found out that Hispanic
American tended to have higher predicted BF% than
African Americans and European Americans at BMI > 30
whereas Hispanic American women tended to have
higher predicted BF% than the other two ethnic groups at
BMI < 30. The aforementioned authors discuss that these
differences can be explained in terms of different ancestry
background and cultural/lifestyle of Hispanic groups. We
agree with the authors in regard to the importance of evalu-
ating the influence of European, African and Indian ances-
try on BF% and if cultural-economic-environment factors
influence this relationship in different contexts.
Sanchez-Castillo et al. [29] using data from a nation-
wide representative sample found that the BMI cutoff
point for hypertension was 26.6 in men and 27.8 in
women. Our cutoff for hypertension in men was similar
to the one reported by Sanchez-Castillo but differed by
about 1.2 points in women.
Men and women in the present study have higher edu-
cation levels and lower prevalence of metabolic syndrome
than the general Mexican population, so our results may
not be as representative as those obtained by nationwide
surveys; this limits the generalizability of our results.
Nonetheless, overall our findings can be useful for evaluat-
ing people with ethnic, socioeconomic, and physical char-
acteristics similar to our study participants.
While our approach for obtaining optimal classification
cutoffs was focused on accuracy alone, other aspects such
as the metabolic risk factors prevalence and the associated
treatment costs might be considered as well in future re-
searches. To our knowledge this is the first study to com-
pare the BF% international cutoffs in Mexican population
and assess their association with metabolic risk factors. Fu-
ture studies with population representativeness are required
to clarify the relationship between BF% and obesity related
indicators of morbidity.
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In the present study BMI and WC showed better accur-
acy than BF% for detecting metabolic risk factors. BF%
international cutoffs had very low specificity and thus a
high rate of false positives for both sexes.
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